Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tarceva receives second fast track designation

Sep. 25, 2002

FDA issues approvable letter for Metvix

Sep. 25, 2002

Worldwide development and marketing agreement for epothilone D in cancer

Sep. 25, 2002

New product for cancer heading for clinical testing at ProMetic

Sep. 25, 2002

Novel VEGFR inhibitors prepared and tested at Taisho

Sep. 25, 2002

GSK designs new series of antiangiogenic agents

Sep. 23, 2002

Hybridon and Aegera collaborate to develop antisense drug targeting XIAP gene

Sep. 23, 2002

Access Oncology obtains rights to develop and market antitumor alkylphosphocholine

Sep. 23, 2002

New data on the antiangiogenic effects of endostatin against advanced solid tumors

Sep. 23, 2002

Favorable pharmacokinetic profile described for new camptothecin analogue DRF-1042

Sep. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...